Fasting-mimicking diet with chemotherapy for breast cancer
Part of Cancer, Skin clinical trials.
This trial adds a fasting-mimicking diet to standard chemotherapy before surgery for a specific type of breast cancer. The diet may help make the chemotherapy work better while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a specific type of breast cancer (estrogen receptor positive, HER2 negative) that is invasive ductal carcinoma.
- Your cancer is at a stage where chemotherapy before surgery is recommended (based on tumor size, lymph node involvement, or grade).
- You are between 18 and 75 years old and have a BMI of at least 18.5.
- You have adequate blood counts and organ function (your doctor will check this).
- You have not had chemotherapy for this breast cancer before.
- You do not have uncontrolled diabetes, thyroid disease, autoimmune disease requiring medication, or are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.
This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.
This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.
This trial studies whether a 14-hour night fast and 10-hour eating window can improve inflammation markers and quality of life in women with HR+/HER2- early breast cancer. You would start the fasting routine within three months of beginning hormone therapy.
This trial tests whether a specific nutrition supplement (amino acids and flavonoids) can lessen chemotherapy side effects, support nutrition, and improve quality of life in people with non-metastatic breast cancer. It focuses on women who are receiving certain chemotherapy medicines and can eat by mouth and attend regular visits.
This trial tests whether an intermittent, fasting-like diet can help control metastatic prostate cancer and improve metabolic health in men on hormone therapy. Participants follow a specific diet plan and are monitored by the study team.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.